Your browser is no longer supported. Please, upgrade your browser.
AAAP Advanced Accelerator Applications S.A. daily Stock Chart
AAAP [NASD]
Advanced Accelerator Applications S.A.
Index- P/E- EPS (ttm)-1.55 Insider Own41.72% Shs Outstand44.20M Perf Week-0.09%
Market Cap3.60B Forward P/E- EPS next Y-0.58 Insider Trans- Shs Float4.69M Perf Month0.67%
Income-69.00M PEG- EPS next Q-0.25 Inst Own39.00% Short Float4.94% Perf Quarter41.47%
Sales158.30M P/S22.76 EPS this Y-24.00% Inst Trans4.23% Short Ratio0.29 Perf Half Y118.58%
Book/sh7.11 P/B11.47 EPS next Y36.30% ROA-14.50% Target Price72.83 Perf Year193.27%
Cash/sh5.13 P/C15.88 EPS next 5Y- ROE-20.40% 52W Range23.50 - 81.75 Perf YTD204.67%
Dividend- P/FCF- EPS past 5Y- ROI-6.30% 52W High-0.27% Beta-
Dividend %- Quick Ratio5.20 Sales past 5Y26.40% Gross Margin74.20% 52W Low246.94% ATR0.18
Employees501 Current Ratio5.50 Sales Q/Q39.30% Oper. Margin-21.30% RSI (14)68.96 Volatility0.22% 0.24%
OptionableYes Debt/Eq0.05 EPS Q/Q-224.00% Profit Margin-43.60% Rel Volume0.61 Prev Close81.59
ShortableYes LT Debt/Eq0.04 EarningsNov 27 BMO Payout- Avg Volume787.48K Price81.53
Recom2.30 SMA200.19% SMA505.10% SMA20058.19% Volume480,100 Change-0.07%
Nov-20-17Downgrade JP Morgan Overweight → Neutral
Oct-30-17Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jul-27-17Upgrade JMP Securities Mkt Perform → Mkt Outperform
Jun-15-17Initiated JP Morgan Overweight $50
Dec-22-16Downgrade JMP Securities Mkt Outperform → Mkt Perform
Nov-29-16Downgrade Wells Fargo Outperform → Market Perform
Oct-18-16Initiated Wells Fargo Outperform
Dec-07-15Initiated JMP Securities Mkt Outperform $44
Dec-07-15Initiated Jefferies Buy $33
Dec-07-15Initiated Citigroup Buy $32
Dec-07-15Initiated Canaccord Genuity Buy $35
Dec-11-17 11:02AM  December Top Growth Companies Simply Wall St.
Dec-07-17 07:50AM  Free Research Report as IDEXX Laboratories Revenue Grew 9.7% and EPS Surged 27.4% ACCESSWIRE
07:00AM  Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer GlobeNewswire
01:01AM  Novartis tender offer for Advanced Accelerator Applications commences GlobeNewswire
Dec-05-17 04:00PM  Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by Novartis GlobeNewswire
Nov-20-17 07:15AM  The Market In 5 Minutes: Bitcoin Rally, An IPO Winner, Trump Tweets, And More Benzinga
Nov-17-17 07:39AM  Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017 GlobeNewswire
Nov-07-17 01:08PM  Here's Why Advanced Accelerator Application SA Rose 20% in October Motley Fool
Nov-03-17 03:11AM  Novartis to buy French cancer specialist AAA for $3.9 billion Reuters
Nov-02-17 09:05AM  Now that Novartis is buying AAA, Im zeroing in on this potential pharma target MarketWatch
Oct-31-17 04:51PM  Novartis Buys French Radiopharmaceutical Company Zacks
08:59AM  Advanced Accelerator (AAAP) in Focus: Stock Moves 10.4% Higher Zacks
Oct-30-17 12:36PM  Why Advanced Accelerator Applications SA Acquired a Higher Price Today Motley Fool +10.41%
10:40AM  Why Novartis Is Moving to Acquire Advanced Accelerator Applications 24/7 Wall St.
08:43AM  Stock Futures Lower as Manafort Told to Surrender in Mueller Probe TheStreet.com
08:18AM  Novartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens TheStreet.com
07:37AM  Novartis to buy French cancer specialist AAA for $3.9 billion Reuters
07:37AM  Novartis to buy French cancer specialist AAA for $3.9 bln Reuters
06:16AM  Novartis to buy cancer specialist AAA for $3.9 billion Reuters
06:06AM  Novartis To Buy Advanced Accelerator for $3.9 Billion in Oncology Push TheStreet.com
04:40AM  European shares open sideways as earning roll in, Spain rebounds Reuters
02:30AM  Novartis to buy France's Advanced Accelerator for $3.9 bln Reuters
02:01AM  Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio GlobeNewswire
02:00AM  Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis GlobeNewswire
Oct-02-17 09:30AM  Advanced Accelerator (AAAP) Cancer Therapy Approved in EU Zacks
Sep-29-17 02:40PM  Big Dose Of Healthy News Sends Biotech Stocks To New Heights Investor's Business Daily
09:16AM  Advanced Accelerator Applications Announces European Approval of Lutetium (177Lu) Oxodotreotide (Lutathera®) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors GlobeNewswire
Sep-28-17 04:50PM  Novartis Could Acquire This Biotech Why A Deal Is 'Very Logical' Investor's Business Daily +8.94%
11:56AM  Why Advanced Accelerator Application SA Stock Jumped Higher Today Motley Fool
07:10AM  3 Stocks to Watch on Thursday: Advanced Accelerator Application SA(ADR) (AAAP), Jabil Inc (JBL) and Medtronic Plc. (MDT) InvestorPlace
Sep-22-17 07:20AM  Earnings Review and Free Research Report: Advanced Accelerators Revenue Increased 32% ACCESSWIRE
Sep-06-17 11:03AM  CORRECTING and REPLACING -- Advanced Accelerator Applications S.A. GlobeNewswire
08:41AM  Advanced Accelerator Applications (AAAP) in Focus: Stock Moves 7.5% Higher Zacks
08:28AM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 6, 2017 Capital Cube
07:00AM  Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lutetium Lu 177 Dotatate* (Lutathera®) GlobeNewswire
Aug-31-17 07:00AM  Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017 GlobeNewswire
Aug-29-17 05:46PM  Advanced Accelerator Gets Action Date for Lutathera from FDA Zacks
Aug-28-17 10:08AM  Advanced Accelerator Applications Announces New Prescription Drug User Fee Act (PDUFA) date of January 26, 2018, for Lutetium Lu 177 Dotatate (Lutathera®) GlobeNewswire
Aug-04-17 11:48AM  Zacks.com featured highlights: Columbus McKinnon, The New York Times, Advanced Accelerator Applications, Enanta Pharmaceuticals and Caesars Entertainment Zacks
Jul-27-17 07:00AM  Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA GlobeNewswire
Jul-25-17 08:20AM  Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7% Zacks
Jul-21-17 08:30AM  Advanced Accelerator Applications Announces Positive CHMP Opinion Recommending Approval of Lutetium 177Lu Oxodotreotide (Lutathera®) for Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors GlobeNewswire
Jul-11-17 01:54PM  ETFs with exposure to Advanced Accelerator Applications SA : July 11, 2017 Capital Cube
Jun-27-17 02:47PM  ETFs with exposure to Advanced Accelerator Applications SA : June 27, 2017 Capital Cube
Jun-16-17 03:18PM  ETFs with exposure to Advanced Accelerator Applications SA : June 16, 2017 Capital Cube
Jun-14-17 09:41AM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-02-17 08:15AM  Blog Coverage Chembio Announces Major Leadership Shuffle as CEO Sperzel Takes Medical Leaves Accesswire -5.15%
May-31-17 07:00AM  Advanced Accelerator Applications Reports 21% Sales Growth for First Quarter 2017 GlobeNewswire
May-30-17 08:36AM  Advanced Accelerator Applications and Blue Earth Diagnostics Announce European Manufacturing and Distribution Agreements for Axumin (Fluciclovine (18F)) for PET Imaging of Recurrent Prostate Cancer GlobeNewswire
May-25-17 07:00AM  Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors GlobeNewswire
May-18-17 07:00AM  Advanced Accelerator Applications Receives 2017 Industry Innovation Award from National Organization for Rare Disorders for NETSPOT®, a Diagnostic Drug for Neuroendocrine Tumors GlobeNewswire
May-01-17 03:31PM  ETFs with exposure to Advanced Accelerator Applications SA : May 1, 2017 Capital Cube
Apr-20-17 02:09PM  ETFs with exposure to Advanced Accelerator Applications SA : April 20, 2017 Capital Cube
Apr-10-17 01:40PM  ETFs with exposure to Advanced Accelerator Applications SA : April 10, 2017 Capital Cube
Apr-07-17 02:58PM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q4, 2016 By the Numbers : April 7, 2017 Capital Cube
12:28PM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: 2016 By the Numbers : April 7, 2017 Capital Cube
Mar-30-17 07:30AM  Advanced Accelerator Applications Signs Strategic Supply Agreement with University of Missouri for Lutetium 177 GlobeNewswire
Mar-25-17 12:01AM  Today's Strong Buys Breaking Out to New Highs Zacks
Mar-23-17 07:35PM  Edited Transcript of AAAP earnings conference call or presentation 23-Mar-17 2:00pm GMT Thomson Reuters StreetEvents +6.11%
07:30AM  Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT® Launch Success GlobeNewswire
07:07AM  Q4 2016 Advanced Accelerator Applications SA Earnings Release - Before Market Open
Mar-22-17 04:05PM  Investor Network Invites You to the Advanced Accelerator Applications Year-End 2016 Earnings Conference Call and Webcast Live on Thursday, March 23, 2017 Accesswire
Mar-20-17 12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs MarketWatch
12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs at MarketWatch
Mar-15-17 07:00AM  Advanced Accelerator Applications to Announce Full-Year 2016 Financial Results on March 23 GlobeNewswire
Mar-14-17 08:30AM  Calithera Biosciences (CALA) Rises: Stock Moves Up 19.3% Zacks
Mar-09-17 09:27AM  New Strong Buy Stocks for March 9th Zacks
Mar-06-17 07:00AM  Advanced Accelerator Applications Announces Presentation of Quality of Life Findings from NETTER-1 Phase III Study at ENETS GlobeNewswire
Mar-01-17 07:00AM  Advanced Accelerator Applications Announces Addition of NETSPOT® to National Comprehensive Cancer Network® Guidelines for Evaluation of NETs GlobeNewswire
Feb-13-17 08:15AM  Advanced Accelerator (AAAP) Catches Eye: Stock Jumps 5.4%
Jan-12-17 08:05AM  Advanced Accelerator Applications Announces New England Journal of Medicine Publication of Lutathera® NETTER-1 Phase III Results GlobeNewswire
Jan-11-17 12:30PM  ETFs with exposure to Advanced Accelerator Applications SA : January 11, 2017
Jan-09-17 07:00AM  Advanced Accelerator Applications CEO Provides Progress Report on Corporate Developments of 2016; Asserts Confidence in Ability to Address FDA Comments on Lutathera® NDA GlobeNewswire
Jan-04-17 07:00AM  Advanced Accelerator Applications to Present at 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-22-16 06:59AM  Advanced Accelerator Applications downgraded by JMP Securities
Dec-21-16 07:00AM  Advanced Accelerator Applications Receives Complete Response Letter from FDA for Lutathera®, an Investigational Treatment for Neuroendocrine Tumors GlobeNewswire -5.84%
Dec-15-16 07:00AM  Advanced Accelerator Applications Announces European Commission Approval of SomaKit TOC GlobeNewswire
Dec-12-16 07:45PM  Is Advanced Accelerator Application SA (ADR) (AAAP) a Good Stock to Buy? at Insider Monkey
Dec-08-16 07:00AM  Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT® GlobeNewswire
Dec-06-16 01:40PM  Is Herc Holdings Inc. (HRI) Worthy of Your Portfolio? at Insider Monkey
Nov-30-16 08:45AM  Aclaris Therapeutics (ACRS) Worth Watching: Stock Up 7.5%
Nov-29-16 09:24AM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
02:06AM  Edited Transcript of AAAP earnings conference call or presentation 28-Nov-16 9:30pm GMT
Nov-28-16 09:00AM  Investor Calendar Invites You to the Advanced Accelerator Applications Third Quarter 2016 Earnings Conference Call and Webcast Live on Monday, November 28, 2016 Accesswire -10.35%
08:30AM  IntelliPharmaCeutics (IPCI) Jumps: Stock Adds 5% in Session
07:34AM  Advanced Accelerator reports 3Q loss
07:07AM  Q3 2016 Advanced Accelerator Applications SA Earnings Release - Before Market Open
07:00AM  Advanced Accelerator Applications Reports 15.4% Sales Growth in the Third Quarter of 2016 and Feedback from the FDA for Lutathera®, an Investigational Treatment for Neuroendocrine Tumors GlobeNewswire
Nov-24-16 05:48PM  The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 at Insider Monkey
Nov-23-16 07:30AM  Advanced Accelerator Applications to Announce Third Quarter and Nine-Month 2016 Financial Results on November 28 GlobeNewswire
Nov-18-16 07:42AM  Is a Surprise in Store for Medtronic (MDT) in Q2 Earnings?
Nov-17-16 09:25AM  Patterson Companies (PDCO) Q2 Earnings: What's in Store?
09:14AM  Can Veeva Systems (VEEV) Pull a Surprise in Q3 Earnings?
08:52AM  Deere (DE) to Report Q4 Earnings: What's in the Cards?
Nov-15-16 08:25AM  Xencor (XNCR) Looks Good: Stock Adds 13.2% in Session
Nov-14-16 09:33AM  Why Concordia International (CXRX) Could Be Positioned for a Slump
Nov-11-16 08:35AM  Corcept (CORT) Looks Good: Stock Jumps 6.5% in Session
Nov-02-16 07:00AM  Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products GlobeNewswire
Oct-28-16 09:30AM  Zacks.com featured highlights: Primo Water, Horizon Global, Hallador Energy and Advanced Accelerator Applications S.A.
Oct-27-16 08:46AM  Stay Ahead of Time: Buy 4 Stocks with Recent Price Strength
Advanced Accelerator Applications SA is a radiopharmaceutical company that develops, produces and sells molecular nuclear medicine (MNM), diagnostic and therapeutic products. The Company's lead therapeutic candidate, Lutathera, is being developed for the treatment of midgut neuroendocrine tumors (NETs). The Company has a portfolio of six diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. Its products in clinical development include Lutathera, Somakit and Annexin V-128. The Company's commercial products include Gluscan /Gluscan 500/Barnascan, IASOflu, IASOdopa, IASOcholine, MIBITEC/Adamibi and Leukokit. Lutathera is a solution of a Lu-177-labeled analogue of somatostatin, a hormone that acts as a regulator of the endocrine system. Somakit is the Company's companion PET diagnostic product candidate for Lutathera. Annexin V-128 is a SPECT diagnostic candidate for the assessment of apoptotic and necrotic processes.